HARRISBURG, DAUPHIN CO. (WOLF) — Pennsylvania is among a group of states that reached a $4.87 million settlement with GS Labs over allegations the company overcharged patients for COVID-19 testing and failed to provide test results within promised timeframes.
Attorney General Dave Sunday announced Wednesday that Pennsylvanians affected by the settlement may be eligible for restitution and should receive information from GS Labs about how to file claims.
According to the Attorney General’s Office, a multistate investigation found the company engaged in questionable testing and billing practices during the COVID-19 pandemic between 2020 and 2022.
Investigators alleged GS Labs advertised inflated cash prices for COVID-19 tests, in some cases charging as much as $380 for a single test and nearly $1,000 for certain multi-panel tests. Officials said those listed prices were used to justify higher charges to insurance companies, while some cash-paying customers still paid significantly more than prevailing market rates.
The investigation also found the company failed to deliver test results within its advertised three-day turnaround time for hundreds of thousands of patients. In some cases, patients reportedly waited a week or longer to receive results.
Additionally, officials alleged GS Labs charged administrative fees of up to $49 per test to approximately 70,000 patients despite advertising that insured customers would not face out-of-pocket costs.
Under the settlement, GS Labs will provide $3.6 million in restitution to affected consumers. The agreement includes:
$1.8 million for cash-paying patients who were overcharged for testing.$1.7 million for patients who were charged administrative fees.More than $33,000 for cash-paying patients who did not receive test results within three days.An online restitution program will be created and funded by GS Labs, with oversight from the participating states.The company will also pay an additional $1.25 million to the multistate coalition.
GS Labs has stated it is no longer operating and does not currently provide testing services. If the company resumes operations in the future, the settlement requires changes to its advertising and sales practices.
In announcing the settlement, Sunday said consumers deserved fair pricing and timely medical testing during the pandemic.
“Pennsylvanians deserve medical testing with integrity, fair pricing, and timely results,” Sunday said in a statement. “This settlement will return money to Pennsylvanians who were relying on this company to provide critical and timely medical information.”
The settlement was led by attorneys general from Kansas, Minnesota, Nebraska and Washington, with Pennsylvania among more than a dozen states joining the agreement.